Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
WNT signaling underlies the pathogenesis of neuropathic pain in rodents
Yan-Kai Zhang, … , Angela A. Song, Xue-Jun Song
Yan-Kai Zhang, … , Angela A. Song, Xue-Jun Song
Published April 15, 2013
Citation Information: J Clin Invest. 2013;123(5):2268-2286. https://doi.org/10.1172/JCI65364.
View: Text | PDF
Research Article Neuroscience

WNT signaling underlies the pathogenesis of neuropathic pain in rodents

  • Text
  • PDF
Abstract

Treating neuropathic pain is a major clinical challenge, and the underlying mechanisms of neuropathic pain remain elusive. We hypothesized that neuropathic pain–inducing nerve injury may elicit neuronal alterations that recapitulate events that occur during development. Here, we report that WNT signaling, which is important in developmental processes of the nervous system, plays a critical role in neuropathic pain after sciatic nerve injury and bone cancer in rodents. Nerve injury and bone cancer caused a rapid-onset and long-lasting expression of WNTs, as well as activation of WNT/frizzled/β-catenin signaling in the primary sensory neurons, the spinal dorsal horn neurons, and astrocytes. Spinal blockade of WNT signaling pathways inhibited the production and persistence of neuropathic pain and the accompanying neurochemical alterations without affecting normal pain sensitivity and locomotor activity. WNT signaling activation stimulated production of the proinflammatory cytokines IL-18 and TNF-α and regulated the NR2B glutamate receptor and Ca2+-dependent signals through the β-catenin pathway in the spinal cord. These findings indicate a critical mechanism underlying the pathogenesis of neuropathic pain and suggest that targeting the WNT signaling pathway may be an effective approach for treating neuropathic pain, including bone cancer pain.

Authors

Yan-Kai Zhang, Zhi-Jiang Huang, Su Liu, Yue-Peng Liu, Angela A. Song, Xue-Jun Song

×

Figure 8

Intrathecal administration of WNT production inhibitor IWP-2 or WNT scavenger Fz-8/Fc suppresses neurochemical signs of NP as well as NR2B and the subsequent Ca2+-dependent signals in rat SC.

Options: View larger image (or click on image) Download as PowerPoint
Intrathecal administration of WNT production inhibitor IWP-2 or WNT scav...
(A) Confocal images showing inhibitory effects of IWP-2 on induction of c-Fos, activation of astrocytes (GFAP), and microglial cells (IBA1). Original magnification, ×200. (B) Data summary of A. IWP-2 (20 μM, i.t.) was given once a day on postoperative days 7, 8, and 9, respectively. Tissues were collected 4 hours after the last injection (20 SC sections in each group). Data are expressed as the mean ± SEM. One-way ANOVA, *P < 0.05, **P < 0.01 versus sham; ##P < 0.01 versus CCI. (C) Western blot showing inhibitory effects of Fz-8/Fc on CCI-induced increased phosphorylation of NR2B, CaMKII, Src, PKCγ, ERK, and CREB. Fz-8/Fc (4 μg, i.t.) was given once a day on postoperative days 7, 8, and 9, respectively. Tissues were collected 4 hours after the last injection (n = 4 each group). (D) Data summary of C. One-way ANOVA, *P < 0.05, **P < 0.01 versus sham; #P < 0.05, ##P < 0.01 versus CCI + PBS.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts